Aureka Biotechnologies Closes $35 Million Series A+ Funding Round
AI-driven antibody drug development company Aureka Biotechnologies has closed a $35 million Series A+ funding round led …
🏷️ Antibody Drugs
1 articles about 'Antibody Drugs'
1